The global Sacroiliac Joint Fusion market size is expected to be worth around US$ 761.45 million by 2030, according to a new report by Vision Research Reports.
The global Sacroiliac Joint Fusion market size was valued at US$ 190.5 million in 2020 and is anticipated to grow at a CAGR of 18.5% during forecast period 2021 to 2030.
Report Coverage
Report Scope | Details |
Market Size | US$ 761.45 million by 2030 |
Growth Rate | CAGR of 18.5% From 2021 to 2030 |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Indication, Surgery Type, Product, End-user |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | SI-BONE, Inc.; SIGNUS Medizintechnik GmbH; Globus Medical; Orthofix Medical Inc.; Life Spine, Inc.; Camber Spine Technologies, LLC; CoreLink Surgical; Xtant Medical; Surgalign Spine Technologies, Inc.; Medtronic |
Growth Factors
Growing technological developments, the number of minimally invasive surgical procedures, reimbursement coverage, and initiatives by key companies are some of the key drivers of this market. As per AmeriHealth Caritas, by 2020, minimally invasive sacroiliac joint fusion was covered by Medicaid programs in 44 states in the U.S. while 32 Blue Cross Blue Shield plans covered minimally invasive joint fusion by 2019. This is anticipated to increase the number of MIS sacroiliac joint fusion procedures.
The COVID-19 pandemic resulted in logistical bottlenecks, decreased sales and marketing activities, low demand, and other challenges for market participants. The major impact during the pandemic, however, was canceled or postponed elective surgeries. As many countries went under lockdown and implemented movement restrictions, the number of elective surgeries plummeted. In addition, several healthcare institutions and regulatory bodies recommended the postponement of elective surgical procedures.
By Indication Analysis
The degenerative sacroilitis segment held the largest revenue share of over 35.0% in 2020. The key factors contributing to this segment growth include a high prevalence of degenerative sacroilitis, growing awareness regarding the condition, and improving diagnostic capabilities for sacroiliac joint disorders.
The trauma segment is expected to expand at the highest CAGR of 18.7% from 2021 to 2030. Trauma indication is one of the most recently approved indications by the FDA, thus contributing to the segment growth.
By Surgery Type Analysis
The minimally invasive surgeries (MIS) segment held the largest revenue share of over 91.0% in 2020 and is estimated to expand at the fastest growth rate over the forecast period. The increasing preference for minimally invasive surgeries due to associated benefits such as smaller incisions.
According to the Washington State Health Care Authority’s 2021 report, minimally invasive SI joint fusion surgery was found to be more effective than open fusion for reducing pain. It is also associated with a shorter length of stay at the hospital.
By Product Analysis
The implants segment accounted for the largest revenue share of over 70.0% in 2020 and is projected to expand at the highest CAGR over the forecast period. The key factors contributing to the segment growth include the rising demand for safe and effective sacroiliac joint fusion systems and advancements in technology and materials used in these systems.
3D printing technology is gaining popularity in various applications of MIS such as bio modeling to optimize preoperative planning, manufacturing of implants, and hardware templates and guides.
By End-user Analysis
The hospitals segment dominated the market with a revenue share of over 45.0% in 2020. The key factors contributing to the segment growth include a higher volume of surgeries performed in hospitals and a growing preference for minimally invasive surgeries.
According to the Centers for Medicare & Medicaid Services (CMS), in March 2021, there were around 187 Medicare-certified ASCs in Washington state, 442 in Texas, 457 in Florida, 817 in California, and 368 in Georgia. In fact, as per Definitive Healthcare, LLC, there were about 9,280 active ASCs in 2019 in the U.S. These numbers are anticipated to increase over the forecast period.
By Regional Analysis
North America held the largest revenue share of over 40.0% in 2020. The growth of the regional market can be attributed to the presence of key players, advanced healthcare infrastructure, and growing reimbursement coverage. Asia Pacific is projected to expand at the fastest CAGRof 19.1% over the forecast period.
SI-BONE, Inc. reported the first iFuse procedures beyond its key markets of Europe and the U.S., in countries such as Canada, Israel, Japan, Australia, Hong Kong, New Zealand, Saudi Arabia, South Africa, and Turkey, thus expanding its regional presence.
Key Players
SI-BONE, Inc.
SIGNUS Medizintechnik GmbH
Globus Medical
Orthofix Medical Inc.
Life Spine, Inc.
Camber Spine Technologies, LLC
CoreLink Surgical
Xtant Medical
Surgalign Spine Technologies, Inc.
Medtronic
Market Segmentation
By Indication
Degenerative Sacroilitis
Sacral Disruption
Trauma
By Surgery Type
MIS
Open
By Product
Implants
Accessories
By End-user
Hospitals
Ambulatory Surgical Centers
Others (Specialty Centers, Research & Academic Institutes)
Regional
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
MEA
South Africa
Saudi Arabia
The Sacroiliac Joint Fusion market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Sacroiliac Joint Fusion market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Sacroiliac Joint Fusion market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sacroiliac Joint Fusion market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Sacroiliac Joint Fusion market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Sacroiliac Joint Fusion capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Sacroiliac Joint Fusion by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Sacroiliac Joint Fusion market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Sacroiliac Joint Fusion market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Sacroiliac Joint Fusion market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Sacroiliac Joint Fusion industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Sacroiliac Joint Fusion market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Sacroiliac Joint Fusion market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Sacroiliac Joint Fusion market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Sacroiliac Joint Fusion market. These factors have benefited the growth of the global market for Sacroiliac Joint Fusion. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Sacroiliac Joint Fusion. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Sacroiliac Joint Fusion are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Product Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Sacroiliac Joint Fusion Market, By Indication
7.1. Sacroiliac Joint Fusion Market, by Indication, 2021-2030
7.1.1. Degenerative Sacroilitis
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Sacral Disruption
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Trauma
7.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Sacroiliac Joint Fusion Market, By Surgery Type
8.1. Sacroiliac Joint Fusion Market, by Surgery Type, 2021-2030
8.1.1. MIS
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Open
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Sacroiliac Joint Fusion Market, By Product
9.1. Sacroiliac Joint Fusion Market, by Product, 2021-2030
9.1.1. Implants
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Accessories
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Sacroiliac Joint Fusion Market, By End-user
10.1. Sacroiliac Joint Fusion Market, by End-user, 2021-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Ambulatory Surgical Centers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Others (Specialty Centers, Research & Academic Institutes)
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Sacroiliac Joint Fusion Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Indication (2017-2030)
11.1.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.1.3. Market Revenue and Forecast, by Product (2017-2030)
11.1.4. Market Revenue and Forecast, by End-user (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Indication (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.4. Market Revenue and Forecast, by End-user (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Indication (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Product (2017-2030)
11.1.6.4. Market Revenue and Forecast, by End-user (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Indication (2017-2030)
11.2.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.2.3. Market Revenue and Forecast, by Product (2017-2030)
11.2.4. Market Revenue and Forecast, by End-user (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Indication (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.4. Market Revenue and Forecast, by End-user (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Indication (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.4. Market Revenue and Forecast, by End-user (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Indication (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.4. Market Revenue and Forecast, by End-user (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Indication (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Product (2017-2030)
11.2.8.4. Market Revenue and Forecast, by End-user (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Indication (2017-2030)
11.3.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.3.3. Market Revenue and Forecast, by Product (2017-2030)
11.3.4. Market Revenue and Forecast, by End-user (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Indication (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.4. Market Revenue and Forecast, by End-user (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Indication (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.4. Market Revenue and Forecast, by End-user (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Indication (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.4. Market Revenue and Forecast, by End-user (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Indication (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Product (2017-2030)
11.3.8.4. Market Revenue and Forecast, by End-user (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Indication (2017-2030)
11.4.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.4.3. Market Revenue and Forecast, by Product (2017-2030)
11.4.4. Market Revenue and Forecast, by End-user (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Indication (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.4. Market Revenue and Forecast, by End-user (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Indication (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.4. Market Revenue and Forecast, by End-user (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Indication (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.4. Market Revenue and Forecast, by End-user (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Indication (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Product (2017-2030)
11.4.8.4. Market Revenue and Forecast, by End-user (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Indication (2017-2030)
11.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.5.3. Market Revenue and Forecast, by Product (2017-2030)
11.5.4. Market Revenue and Forecast, by End-user (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Indication (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.4. Market Revenue and Forecast, by End-user (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Indication (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Product (2017-2030)
11.5.6.4. Market Revenue and Forecast, by End-user (2017-2030)
Chapter 12. Company Profiles
12.1. SI-BONE, Inc.
12.1.1. Company Overview
12.1.2. Indication Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. SIGNUS Medizintechnik GmbH
12.2.1. Company Overview
12.2.2. Indication Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Globus Medical
12.3.1. Company Overview
12.3.2. Indication Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Orthofix Medical Inc.
12.4.1. Company Overview
12.4.2. Indication Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Life Spine, Inc.
12.5.1. Company Overview
12.5.2. Indication Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Camber Spine Technologies, LLC
12.6.1. Company Overview
12.6.2. Indication Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CoreLink Surgical
12.7.1. Company Overview
12.7.2. Indication Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Xtant Medical
12.8.1. Company Overview
12.8.2. Indication Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Surgalign Spine Technologies, Inc.
12.9.1. Company Overview
12.9.2. Indication Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Medtronic
12.10.1. Company Overview
12.10.2. Indication Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms